Persistence of antibody to 23-valent pneumococcal polysaccharide vaccine: a 5-year prospective follow-up cohort study

Background Pneumococcal vaccines are effective in preventing pneumococcal diseases in adults. The evaluation of the antibodies persistence to the 23-valent pneumococcal polysaccharide vaccine (PPV23) could provide evidence on PPV23 revaccination.Research design and methods Adults aged ≥ 60 years wer...

وصف كامل

التفاصيل البيبلوغرافية

الحاوية / القاعدة:	Expert Review of Vaccines
المؤلفون الرئيسيون:	Xiang Guo, Juan Li, Jing Qiu, Rui Zhang, Jia Ren, Zhuoying Huang, Zhi Li, Xiufang Liang, Fang Lan, Juan Chen, Fang Huang, Xiaodong Sun
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	Taylor & Francis Group 2024-12-01
الموضوعات:	23-valent pneumococcal polysaccharide vaccine pneumococcal disease immunogenicity older adults antibody persistence
الوصول للمادة أونلاين:	https://www.tandfonline.com/doi/10.1080/14760584.2023.2296934